ASBrS symposium video on multidisciplinary treatment planning for selected patients with low-risk breast cancer
Thank you for your interest in IceCure’s ASBrS symposium segment featuring Michael S. Sabel, MD, FACS, FSSO, William W. Coon Professor of Surgical Oncology at the University of Michigan. This page hosts the full-length video on breast cancer cryoablation, de-escalation of care, and the role of multidisciplinary decision-making. Specifically, this segment discusses select patients with low-risk breast cancer.
Key Highlights for Breast Cancer Cryoablation in a Multidisciplinary De-Escalation Clinic
- Breast cancer cryoablation within the broader shift toward personalized, lower-intensity treatment
- How cryoablation fits alongside other de-escalation strategies, including evolving approaches to surgery, axillary staging, radiation therapy, and systemic therapy.
- Understand why clinical evidence, appropriate patient selection, coordinated follow-up, and multidisciplinary collaboration are essential when considering cryoablation for selected patients with early-stage, low-risk breast cancer.
Interested in learning more?
Contact IceCure to request an evaluation and discuss how ProSense® Cryoablation may fit into your breast surgery or breast imaging practice. Our team can provide additional information on clinical considerations, practice workflow, and next steps for institutions interested in exploring breast cancer cryoablation.